Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Urohealth's Osbon, Advanced Surgical mergers expand incontinence, impotence lines.

This article was originally published in The Gray Sheet

Executive Summary

UROHEALTH MORE THAN TRIPLES SALES FORCE WITH OSBON, ADVANCED SURGICAL merger agreements. Announced the week of Sept. 11, the stock-swap deals to acquire Augusta, Georgia-based Osbon Medical Systems and Princeton, New Jersey-based Advanced Surgical would expand Urohealth's sales force to approximately 100 direct representives from the current 30, the company estimates, with 65 reps coming from Osbon and the remainder from Advanced Surgical.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel